Evidence Library

Showing 10 of 397 results.
Kevin Outterson, LLM, JD •
Boston University School of Law
Rosa Rodriguez-Monguio, PhD •
Boston University School of Law

Concerns about a dearth of antibiotic innovation have spurred calls for incentives to speed the development of new antibiotics. The data from this study suggest that policymakers should be focused on the clinical quality of the new drugs, not just the raw number of new drugs introduced to the market each year. In other words, quality over quantity should be the focus.

 
Amy Winterfeld, JD •
National Conference of State Legislators

A variety of laws and legislatively enabled regulations attempt to reduce sodium in the food supply, including lowering the amount of salt in foods served in schools and child care facilities or purchased by state-regulated elder and health care facilities and prisons. Through incentives to develop grocery vendors in areas without them, at least five states provide more low sodium, high potassium fresh fruits and vegetables for our diets.

 
Jennifer Ibrahim, PhD, MPH, MA •
Temple University
Evan Anderson, JD •
Center for Public Health Initiatives, University of Pennsylvania
Scott Burris, JD •
Center for Public Health Law Research
Alexander Wagenaar, PhD •
University of Florida

This study, published in American Journal of Preventive Medicine, details state distracted-driving policy across all 50 states and the District of Columbia. The study finds, as of 2011, 39 states and the District of Columbia had at least one form of restriction on the use of mobile communication devices in effect..

 
Aaron Kesselheim, MD, JD, MPH •
Brigham & Women’s Hospital

Aaron Kesselheim, MD, JD, MPH, of the Division of Pharmacoepidemiology & Pharmacoeconomics at Brigham and Women’s Hospital discusses the effects on medical innovation of statutes that provide additional intellectual property rights or related incentives to pharmaceutical, medical device, and biotechnology developers in the U.S.

 
Stephen Teret, J.D., M.P.H. •
Johns Hopkins University Bloomberg School of Public Health
Lainie Rutkow, JD, PhD •
Johns Hopkins University Bloomberg School of Public Health

The Attorneys General of the 50 states have considerable legal authority to protect the public’s health, yet their role in the development of health policy is often under-appreciated or misunderstood. This article analyses state Attorneys’ General current powers and provides a logic model that illustrates how the use of these powers can lead to the protection and promotion of the public’s health. The article then provides four brief case studies, to demonstrate how state Attorneys General have used their varied powers to influence policy-making and benefit the public’s health.

 

Pages